Janssen Pharmaceutica Products, LP, has received a subpoena from the US Office of Personnel Management, Office of the Inspector General requesting documents related to Risperdal (risperidone), a prescription medication approved to treat schizophrenia and bipolar mania. The company is cooperating in responding to the subpoena. The company is a subsidiary of Johnson & Johnson.